Back

dr. S. (Sander) van Doorn

Assistant Professor

  • Department of General Practice
  • Julius Center Research Program Cardiovascular Epidemiology

dr. S. (Sander) van Doorn

Research Output (14)

Strategies to reduce the use of low-value medical tests in primary care: a systematic review

Takada Toshihiko, Heus Pauline, van Doorn Sander, Naaktgeboren Christiana A., Weenink Jan-Willem, van Dulmen Simone A., Hooft Lotty 1 dec 2020, In: British Journal of General Practice. 70 , p. E858-E865

Diagnosing deep vein thrombosis in cancer patients with suspected symptoms:an individual participant data meta-analysis

Takada Toshihiko, van Doorn Sander, Parpia Sameer, de Wit Kerstin, Anderson David R, Stevens Scott M, Woller Scott C, Ten Cate-Hoek Arina J, Elf Johan L, Kraaijenhagen Roderik A, Schutgens Roger E G, Wells Phil S, Kearon Clive, Moons Karel G M, Geersing Geert-Jan 20 mei 2020, In: Journal of thrombosis and haemostasis : JTH. 18 , p. 2245-2252 8 p.

Integrated management of atrial fibrillation in primary care:results of the ALL-IN cluster randomized trial

van den Dries Carline J, van Doorn Sander, Rutten Frans H, Oudega Ruud, van de Leur Sjef J C M, Elvan Arif, Oude Grave Lisa, Bilo Henk J G, Moons Karel G M, Hoes Arno W, Geersing Geert-Jan 29 feb 2020, In: European heart journal. 41 , p. 2836-2844 9 p.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation:rationale and design of the FRAIL-AF randomised controlled trial

Joosten Linda P T, van Doorn Sander, Hoes Arno W, Nierman Melchior C, Wiersma Nynke M, Koek Huiberdina L, Hemels Martin E W, Huisman Menno V, Roes Kit C, van den Bor Rutger M, Buding Wim F, Rutten Frans H, Geersing Geert-Jan 29 dec 2019, In: BMJ Open. 9

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation

Joosten Linda P.T., Van Doorn Sander, Rutten Frans H., Geersing Geert Jan 4 jun 2019, In: Annals of Internal Medicine. 170 , p. 816-817 2 p.

Op weg naar ‘de beste DOAC’?

van Doorn Sander, Rutten Frans H., Geersing Geert Jan 21 mrt 2019, In: Nederlands Tijdschrift voor Geneeskunde. 163

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation:A prospective cohort study in the Netherlands

Van Doorn Sander, Tavenier Annerien, Rutten Frans H., Hoes Arno W., Moons Karel G.M., Geersing Geert Jan 1 aug 2018, In: BMJ Open. 8

Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation:A meta-analysis of individual participant data of four screening studies

Van Doorn Sander, Geersing Geert Jan, Kievit Rogier F., Van Mourik Yvonne, Bertens Loes C., Van Riet Evelien E.S., Boonman-De Winter Leandra J., Moons Karel G.M., Hoes Arno W., Rutten Frans H. 23 mrt 2018, In: Heart. 104 , p. 1236-1237

De huisarts, atriumfibrilleren en falende beslisregels

van Doorn Sander, Geersing Geert Jan 1 mrt 2018, In: Huisarts en Wetenschap. 61 , p. 27-29 3 p.

Effectiveness of CHA<sub>2</sub>DS<sub>2</sub>-VASc based decision support on stroke prevention in atrial fibrillation:A cluster randomised trial in general practice

van Doorn S., Rutten F. H., O'Flynn C. M., Oudega R., Hoes A. W., Moons K. G.M., Geersing G. J. 1 jan 2018, In: International Journal of Cardiology. 273 , p. 123-129

All Research Output (14)